A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial

發布時間: 2026年11月6日 新聞來源: SCMP 南華早報 查看原文
語音朗讀:
1.0x
A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial

新聞摘要

以下為來源提供的節錄,完整報道請查看原文。

For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes.

Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic.